Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 25, 2009

View Archived Issues

Inhibitors of epithelial cancer stem cells identified with innovative screen

Snapshots of studies of CXA-101 alone and in combination with tazobactam presented at ICAAC: II

Discouraging results reported for bone agent ronacaleret

IPA-3 covalently binds to the regulatory domain of PAK1; new approach for kinase inhibition revealed

Bazedoxifene acetate is safe, tolerated and cost-effective in osteoporotic postmenopausal women

Toremifene prevents bone loss and increases bone mass density in androgen-deprived males

Adenovirus-based gene therapy restores trichromatic vision in adult color-blind primates

Novel IGF-I receptor antagonists identified by US scientists for the treatment of cancer

Roche claims alpha1A-adrenoceptor partial agonists for the treatment of urinary incontinence

Naphthoquinone derivatives for the treatment of leishmaniasis described by German scientists

Abbott describes positive allosteric modulators of alpha7 nicotinic receptor as analgesics

Adolor acquires rights to OpRA III from Lilly

AstraZeneca and Nektar Therapeutics sign agreement for drug development programs

Cell Therapeutics will focus resources on the approval of Opaxio for ovarian cancer

Neuralstem cleared to commence stem cell trial in amyotrophic lateral sclerosis

Sabril launched in U.S. for patients with difficult-to-treat epilepsy

Takeda San Francisco enters into sponsored research agreement with UCSF

Valeant advances retigabine program

Viralytics completes phase I melanoma trial and prepares for phase II

Abbott receives FDA approval for HIV-1/HIV-2 blood screening test

Genomica launches diagnostic kit for H1N1

Celera and Medco evaluate effect of KIF6 testing on statin therapy compliance

Kevetrin delays tumor growth in animal models of drug-resistant breast cancer

Lux Biosciences reports phase I safety and efficacy results for LX-214

Janssen-Cilag's Stelara approved in UK for plaque psoriasis

Modest positive results reported from phase III clinical trial in Thailand of HIV vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...